WAM
OCEA

Wolverine Asset Management’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Wolverine Asset Management’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,742
Closed -$58K – 2337
2022
Q3 		$58K Sell
5,742
-458,997
-99% -$4.68M ﹤0.01% 1563
2022
Q2 		$4.7M Sell
464,739
-2,609
-0.6% -$26.4K 0.05% 332
2022
Q1 		$4.71M Buy
467,348
+36,000
+8% +$361K 0.05% 302
2021
Q4 		$4.31M Buy
+431,348
New +$4.31M 0.04% 342

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Wolverine Asset Management's OCEA Position: Q4 2022 in Review

Wolverine Asset Management sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q4 2022, closing a stake of 5,742 shares — an estimated $58K sold.

Wolverine Asset Management first reported a position in OCEA in Q4 2021 and held it in 4 quarters. The position peaked at $4.71M in Q1 2022. 43 funds tracked by Wall St. Rank hold OCEA as of Q4 2022.

  • Wolverine Asset Management reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Wolverine Asset Management sold 5,742 Ocean Biomedical, Inc. Common Stock shares in Q4 2022, an estimated $58K.
  • Wolverine Asset Management first reported a position in Ocean Biomedical, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • Wolverine Asset Management's Ocean Biomedical, Inc. Common Stock position peaked at $4.71M in Q1 2022.
  • 43 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q4 2022.

Based on Wolverine Asset Management's 13F filing for Q4 2022, filed 1 Feb 2023.